4//SEC Filing
Lovell Stephanie 4
Accession 0001140361-22-023332
CIK 0001755237other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 8:56 PM ET
Size
4.9 KB
Accession
0001140361-22-023332
Insider Transaction Report
Form 4
Lovell Stephanie
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-14+20,000→ 20,000 totalExercise: $0.53Exp: 2032-06-14→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date.
Documents
Issuer
Cyclerion Therapeutics, Inc.
CIK 0001755237
Entity typeother
Related Parties
1- filerCIK 0001772054
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 8:56 PM ET
- Size
- 4.9 KB